How Life Sciences Companies Can Promote Greater Medication Adherence During COVID19 - PharmaExec

As the global COVID-19 pandemic has continued to develop, it has become apparent that people at the highest risk for complications are those who were already experiencing chronic conditions such as diabetes, chronic obstructive pulmonary disease (COPD), asthma and heart disease.
By John Pagliuca & Prasad Dindigal